Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,520 followers.

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? https://t.co/z6lpqOwCi9

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? https://t.co/7J9swNgyhC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.